Tarsus Pharmaceuticals, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
---|---|---|---|---|
![]() ABOS
Acumen Pharmaceuticals, Inc. |
$1.28 | $157.41 M | -0.92 | 51 |
![]() ALDX
Aldeyra Therapeutics, Inc. |
$6.31 | $229.34 M | -6.69 | 9 |
![]() CNTA
Centessa Pharmaceuticals plc |
$17.20 | $884.24 M | -11.32 | 75 |
![]() CNTB
Connect Biopharma Holdings Limited |
$0.89 | $108.00 M | -2.29 | 81 |
![]() DSGN
Design Therapeutics, Inc. |
$4.93 | $217.51 M | -5.61 | 54 |
![]() ELDN
Eledon Pharmaceuticals, Inc. |
$3.63 | $107.05 M | 4.97 | 20 |
![]() ETON
Eton Pharmaceuticals, Inc. |
$15.29 | $92.74 M | -72.9 | 30 |
![]() GLUE
Monte Rosa Therapeutics, Inc. |
$6.73 | $243.38 M | -3.79 | 133 |
![]() GNFT
Genfit S.A. |
$3.64 | $269.95 M | 9.1 | 169 |
![]() HOWL
Werewolf Therapeutics, Inc. |
$1.17 | $151.66 M | -0.71 | 46 |
![]() IKNA
Ikena Oncology, Inc. |
$1.31 | $84.45 M | -1.28 | 10 |
![]() LIAN
LianBio |
$0.32 | $34.47 M | -0.39 | 163 |
![]() NUVB
Nuvation Bio Inc. |
$2.10 | $684.66 M | -0.99 | 220 |
![]() NUVL
Nuvalent, Inc. |
$77.02 | $5.11 B | -19.6 | 142 |
![]() OPT
Opthea Limited |
$3.41 | $214.34 M | -1.52 | 33 |
![]() PEPG
PepGen Inc. |
$2.35 | $537.15 M | -0.82 | 81 |
![]() PHVS
Pharvaris N.V. |
$16.50 | $843.31 M | -5.77 | 92 |
![]() RLYB
Rallybio Corporation |
$0.64 | $61.34 M | -0.48 | 25 |
![]() STOK
Stoke Therapeutics, Inc. |
$9.00 | $774.50 M | -4.33 | 110 |
![]() TRDA
Entrada Therapeutics, Inc. |
$10.81 | $531.37 M | 6.43 | 183 |
![]() TVTX
Travere Therapeutics, Inc. |
$20.87 | $542.80 M | -5.13 | 385 |
![]() TYRA
Tyra Biosciences, Inc. |
$10.74 | $1.04 B | -6.66 | 49 |